Castleark Management’s NuVasive, Inc. NUVA Stock Holding History

Castleark Management’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-106,460	Closed	-$5.23M	–	347
2022 Q2	$5.23M	Buy	106,460 +8,610	+9%	+$462K	0.28%	92
2022 Q1	$5.55M	Buy	+97,850	New	+$5.2M	0.24%	105
2017 Q3	–	Sell	-181,491	Closed	-$14M	–	427
2017 Q2	$14M	Sell	181,491 -6,544	-3%	-$489K	0.46%	63
2017 Q1	$14M	Sell	188,035 -33,870	-15%	-$2.46M	0.44%	64
2016 Q4	$14.9M	Sell	221,905 -14,780	-6%	-$953K	0.48%	50
2016 Q3	$15.8M	Buy	236,685 +35,235	+17%	+$2.24M	0.48%	47
2016 Q2	$12M	Buy	+201,450	New	+$10.9M	0.38%	72
2016 Q1	–	Sell	-113,565	Closed	-$6.14M	–	427
2015 Q4	$6.14M	Sell	113,565 -126,130	-53%	-$6.43M	0.18%	137
2015 Q3	$11.6M	Buy	+239,695	New	+$12.4M	0.37%	69

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CCM

Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Castleark Management's NUVA Position: Q3 2022 in Review

Castleark Management sold out of NuVasive, Inc. (NUVA) in Q3 2022, closing a stake of 106,460 shares — an estimated $5.23M sold.

Castleark Management first reported a position in NUVA in Q3 2015 and held it in 9 quarters. The position peaked at $15.8M in Q3 2016. 232 funds tracked by Wall St. Rank hold NUVA as of Q3 2022.

Castleark Management reported no remaining NuVasive, Inc. position as of Q3 2022 after selling out during the quarter.
Castleark Management sold 106,460 NuVasive, Inc. shares in Q3 2022, an estimated $5.23M.
Castleark Management first reported a position in NuVasive, Inc. in Q3 2015 and held it in 9 quarters.
Castleark Management's NuVasive, Inc. position peaked at $15.8M in Q3 2016.
232 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2022.

Based on Castleark Management's 13F filing for Q3 2022, filed 15 Nov 2022.